Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Research Centre, Egypt | OTHER |
Not provided
Not provided
Not provided
Not provided
Are there differences in outcome of mitral valve replacement with preservation of mitral apparatus among rheumatic and/or ischemic mitral lesions?.
Mitral valve replacement with preservation of leaflets, and added coronary artery-bypass surgery, when indicated, is it a feasible and reproducible procedure?.
The study was designed to compare outcome after prosthetic mitral replacement with preservation of mitral apparatus for rheumatic valve disease with outcome of replacement for ischemic myocardium and mitral valve disease, The outcomes will be guided by clinical assessment. and echo-cardiograph.
Objectives: The aim is to compare outcome of modified preservation of mitral valve apparatus during prosthetic mitral replacement for rheumatic versus myocardial ischemia &mitral valve disease.
Methods ;This prospective cross-sectional comparative study will include 50 patients with isolated rheumatic mitral valve disease (group A) and 50 patients with mitral disease and myocardial ischemia (group B), surgery is expected to be performed between 2017 and 2020 at one center. All patients will have modified preservation of mitral apparatus during prosthetic mitral replacement. Additionally, group B patients will have bypass grafts to left anterior descending and/or posterior descending / right coronary artery. Data will be collected and analyzed.
The Institutional Review Board (IRB), Ethics Committee (EC)-approval and consent of each patient were obtained.
Criteria for inclusion of patients and exclusion of others were determined according to the guide lines.
Statistical analysis::
Qualitative variables and their association among both groups were studied by applying Chi-square test and Fisher Exact test. Quantitative variables among both groups were compared by applying independent samples t-test. P < 0.05 values mean statistically-significant results.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group A | Sham Comparator | 50 patients with isolated rheumatic mitral valve disease (group A) |
|
| Group B | Other | 50 patients with mitral disease and myocardial ischemia (group B) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| St.Jude bi leaflet prosthetic mitral valve to replace the diseased valve with preservation of both leaflets | Device | St.Jude prosthetic(FDA approved) mitral valve replacement with or without coronary artery bypass grafts |
| Measure | Description | Time Frame |
|---|---|---|
| Smoking index | Number of Packs every day X number of years of smoking= Pack.year, | One week before surgery(or during first clinical visit) . |
| Age and gender for each participant | Males above 40 years and Females above 45 years need pre-operative coronary angio-graph | One week before surgery . |
| For each participant: pathological:type of mitral valve lesion | severe stenosis with mitral area < 1 cm square, severe regurgitation, or mixed lesions | Seven days before surgery . |
| For each participant: etiological :type of mitral valve lesion | Rheumatic: distorted thickened leaflets,thickened fibrosed chordae | Seven days before surgery . |
| For each participant: etiological :type of mitral valve lesion | Rheumatic: distorted thickened leaflets,thickened fibrosed chordae or ischemic incompetence | Seven days before surgery- echo-cardiograph. |
| For each participant:, assessing sub-valvular apparatus | Thickened chordae, ruptured chordae, ischemia of papillary muscles or lateral ventricular wall. | One week before surgery. with Echo-cardiograph. |
| Abascal echo-cardiographic mitral valve score (Wilkins score) | :if score is 8 or less it is good for balloon valvo-plasty, if > 8 surgery is recommended ( leaflet mobility, thickness and calcification. Fourthly, sub-valvular thickening., higher scores = more deterioration |
| Measure | Description | Time Frame |
|---|---|---|
| changes on Clinical examination | local and general Examination,: a new murmur, evolving heart failure | Monthly up to 12 months after surgery) |
| Changes in Results of Prothrombin time, concentration and.International normalized ratio |
Not provided
Inclusion Criteria::
Mitral stenosis (MS)
Mitral regurgitation(MR):
* acute severe MR require surgical correction for hemo-dynamics and relief of symptoms .
Chronic primary mitral regurgitation:
* rheumatic heart disease: replacement before irreversible changes occur can be curative.
Mixed Mitral Stenosis and Mitral Regurgitation:
Exclusion criteria
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Mohamed A. allaban, PhD | Suez Canal University, FOM- Research Ethics Committee | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Suez Canal University | Ismailia | +064 | Egypt | |||
| Suez Canal University |
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by H. D. Elayouty, H. S. Hassan and S.A. Elhafeez. The first draft of the manuscript was written by A. H.Elayouty and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Within 360 days
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Aug 1, 2016 |
Not provided
both groups of patients received surgical treatment parallel to each other.
Not provided
Not provided
All roles were unmasked
Not provided
|
| One week before surgery.with Echo-cardiograph |
| left ventricular wall motion abnormality | hypokinesia, Akinesia, Dyskinesia of certain segment(s) | one week before surgery - with an echo-cardiograph |
| Number of participants with Signs of left ventricular dysfunction | low ejection fraction <52%, low stroke volume< 70 ml, low cardiac output <5 litres per minute | seven days before surgery echo-cardiograph examination |
| Number of participants with pre-operative coronary artery disease | Expected on clinical bases and .proved by Echo-cardiograph-findings | seven days before surgery, coronary angio-graph |
| Number of participants with pre-operative ischemic complications | left ventricular thrombi, septal and left ventricular wall thickness in mm . | seven days before surgery echo-cardiograph examination |
| Assessment of any evolving new prosthetic valve dysfunction | Left atrioventricular outflow stenosis, prosthetic dysfunction due to preservation of valve apparatus | intra-operative trans-esophageal echo-cardiograph examination |
| Change in post-operative left ventricular functions | : Low Fractional Shortening < 28% , Ejection fraction < 40%,, increased left ventricular dimensions and volume | 5 days post-operatively and end of 6th and 12 months after surgery with Echo-Cardiograph |
| Change of Prosthetic mitral valve functions | Development of para-valvular leak or central jet of regurgitation or stuck valve by a thrombus | Monthly through study completion up to 12 months after surgery..... with Echo-cardiograph |
Adjust dose of oral anticoagulant.( between double and half to three times the control) Dose usually ranges between 1 and 11 mg warfarin tablet daily.
| .Monthly through study completion up to 12 months. |
| Mortality and Morbidity | cause of mortality, type of morbidity: wound infection, hypertrophied scar, Kiloid Formation | Monthly through study completion up to 12 months. |
| Ismailia |
| 002-064 |
| Egypt |
| Jun 5, 2022 |
| Prot_SAP_000.pdf |
| ID | Term |
|---|---|
| D007511 | Ischemia |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided